Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Pluristem Enters Collaboration With Pharmaceutical Company Innovare R&D to Expand Pluristem’s ARDS Associated With COVID-19 Program to Mexico
Wednesday, December 30, 2020Pluristem Therapeutics Inc a leading regenerative medicine company developing a platform of novel biological therapeutic products announced today it has entered into a collaboration agreement with Mexican pharmaceutical company Innovare RD to expand...
Insilico enters into a collaboration with APRINOIA to apply novel generative AI-powered system
Wednesday, December 30, 2020Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to utilize Insilicos novel generative artificial intelligence AI technology to accelerate the discovery of next generation compounds...
Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health
Tuesday, December 29, 2020Sumitovant Biopharma Ltd the majority shareholder of Myovant Sciences announced that Myovant Sciences a healthcare company focused on redefining care for women and for men and one of the five healthcare companies in the Sumitovant family of companies
Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development
Tuesday, December 29, 2020Soligenix Inc a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today that the National Institute of Allergy and Infectious Diseases NIAID pa...
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar)
Monday, December 28, 2020Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of cancer metabolic autoimmune and other major diseases
A2 Biotherapeutics Enters Into Collaboration Agreement With Merck to Develop Allogeneic Cell Therapy for Solid Tumor Cancers
Thursday, December 24, 2020A Biotherapeutics wwwabiocom a biotechnology company developing innovative cell therapies for cancer patients with solid tumors today announced that it has entered into an agreement with Merck known as MSD outside the United States and Canada
UCSF and BridgeBio Pharma Collaborate to Accelerate the Development of Therapies for Genetic Diseases
Thursday, December 24, 2020UC San Francisco UCSF and BridgeBio Pharma Inc announced a partnership to drive the advancement of academic innovations in genetically driven diseases into potential therapeutics for patients
Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate RNA Splicing for Serious Diseases
Wednesday, December 23, 2020Skyhawk Therapeutics Inc and Vertex Pharmaceuticals Incorporated announced a strategic research collaboration and licensing agreement aimed at the discovery and development of novel small molecules that modulate RNA splicing for the treatment of seri...
LSBio acquires Absolute Antibody Ltd.
Wednesday, December 23, 2020LSBio LSBio a leading provider of antibodies and reagents for life science research is pleased to announce the acquisition of Absolute Antibody Ltd based in Redcar United Kingdom and the subsidiary Kerafast The terms of the transaction were not disc...
Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China
Tuesday, December 22, 2020Shanghai Haini Pharmaceutical Co Ltd Shanghai Haini the subsidiary of Yangtze River Pharmaceutical Group YRPG and Allecra Therapeutics Allecra announced that the companies have signed an exclusive licensing agreement under which Shanghai Haini will m...